VitalConnect VitalPatch ECG Interpretation/Arrhythmia Detection

Mercy Research1 site in 1 countryMay 15, 2020

ConditionsArrythmia, Cardiac

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Arrythmia, Cardiac
Sponsor: Mercy Research
Locations: 1
Primary Endpoint: Reduction in false alarms received from current telemetry monitoring technology
Status: Withdrawn
Last Updated: 5 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

Subjects in this study will wear the VitalPatch with the added ECG Interpretation and arrhythmia detection features which will expedite the identification of patients whose condition may rapidly deteriorate as well as eliminate the majority of non-actionable alarms.

Detailed Description

This project intends to validate, through comparative study, the output of new technologies (ECG Interpretation and arrhythmia detection) to the VistaCenter platform, aiming to replace current telemetry monitoring equipment. The new technology, through the previous Mercy pilot study, has demonstrated greater accuracy in the detection of ventricular tachycardia patterns and other dysrhythmias/arrhythmias, as well as, reducing the volume of false alarms resulting in the mitigation of alarm fatigue experienced by bedside staff and monitor technicians.

Registry

clinicaltrials.gov

Start Date

May 15, 2020

End Date

November 30, 2020

Last Updated

5 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

Mercy Research

Responsible Party

Principal Investigator

Ashok Palagiri

Physician

Mercy Research

Eligibility Criteria

Inclusion Criteria

•Age ≥ 18 years old,
•No skin trauma to the site where the patch will be applied
•No known allergies to hydrocolloid or silicone based adhesives
•Admitted to Mercy Hospital Washington Cardiac Unit on the 5th floor and have been placed in one of the assigned rooms and require cardiac/telemetry monitoring as ordered by their physician